European Virus Archive goes global
European Virus Archive goes global (EVAg)
EVAg is a non profit organisation that mobilises a global network with expertise in virology. EVAg is a network of 25 international laboratories, including 16 EU member state institutions and 9 non-EU institutions, that represent an extensive range of virological disciplines.
Development of innovative tools:
Joint Research Activity (JRA) is used to exchange know-how between EVAg partners and also to create new tools to develop the infrastructure. Another aspect of tool creation is focused on new techniques and concepts to provide easier and less expensive access to virological materials, taking advantage of the recent advances in science including techniques dedicated to:
- sequencing of viral genomes (NGS)
- genome synthesis
- study of the links between infectivity and mutagenesis
- methods for long term virus conservation
- molecular and serological diagnostics
- bioinformatics and genome-based virus classification (taxonomy)
- virus discovery
- in vivo vertebrate and invertebrate animal studies
EVAg will develop a huge number of innovation end points particularly from joint research activities that will enhance virus diagnostics and promote the prospects of creating antiviral approaches. In particular, EVAg will provide the following assets, which will greatly enhance the infrastructure´s capabilities and services (both within the consortium as well as to outside customers):
- Cell lines with an enhanced potential to isolate and produce viruses from primary clinical samples. Cell lines will be published in peer-reviewed scientific journals and provided physically to recipients within the consortium as well as to customers (outside the consortium) as an access.
- Improved approaches to the sequencing of viruses, from field samples, with the intention of discovering novel viruses.
- Antibodies and proteins based on new and available viruses which can be used by the diagnostics industry to create new detection assays, and by research entities across Europe to enhance the capabilities of studying viral life cycles.
- Molecular detection assays for immediate deployment in cases of emerging epidemics. Cooperation agreements have been issued with the WHO and the OIE corresponding to the worldwide institutions in charge of publicising guidelines that refer to diagnostic procedures.
The technical advances of EVAg will lead to heightened attention in the research community to the consortia as well as to manufacturers of diagnostic tools. The participation in ENIVD and WHOCC will ensure dissemination by relating EVAg to the international public health laboratory community during outbreaks and in times when novel diagnostic recommendations are being issued because of (re-) emergence of viruses.
Here you can Browse the catalogue of “products”
Response to Emergence
Preparedness and response to emerging viral diseases will be addressed and developed through interaction with national centres. Partners specializing in this task will generate standard operation procedures (SOP) for the application of all diagnostic methods derived from the project work. Specific attention will be given to the development of a dedicated Intellectual Property Rights policy aiming at encouraging partners to adopt an appropriate and efficient strategy in terms of results and data protection. Best porn site https://noodlemagazine.com - Watch porn. The knowledge and Intellectual Property management will include coverage of intellectual property policy, ownership, disclosure of inventions and licensing.
Direct cooperation with the WHO, OIE, CDCs, ENIVD will ensure and reinforce the authorisation of EVAg to generate and distribute globally, diagnostic materials and protocols in the event of epidemiological emergencies.
…………………………………………………………………………………
The European Virus Archive http://www.european-virus-archive.com/evag-portal
The WHO Virus Archive & Emergencies preparedness, response:
The Department of Pandemic and Epidemic Diseases (PED) develops strategies, initiatives, and mechanisms to address priority emerging and re-emerging epidemic diseases.
Find here the Disease Outbreak News (DONs):
